Cagrilintide (a long-acting amylin analogue) is supplied by Onyx Peptides as a high-purity research material for laboratory use, with tracked, discreet UK dispatch.
What is Cagrilintide?
Cagrilintide is a long-acting analogue of amylin, a hormone released alongside insulin. It was developed by Novo Nordisk.
How Cagrilintide is studied
It has been studied on its own and in combination with semaglutide (known as CagriSema) in late-stage clinical research. In the laboratory it is used to study amylin receptor signalling.
- Amylin receptor pharmacology
- Combination research with GLP-1 agonists
Cagrilintide from Onyx Peptides
We supply cagrilintide in 5 mg vials. Every batch is independently tested by HPLC to ≥99% purity before it is listed, and carries a batch number that links to its certificate of analysis.
-
Metabolic Research
Cagrilintide (5mg)
Original price was: £56.99.£27.99Current price is: £27.99.£5.60 / mg Read more
Storage and delivery
Supplied as a lyophilised (freeze-dried) powder in a sealed glass vial. Store the sealed vial frozen (below −18 °C) and away from light.
Orders are dispatched from the UK by tracked delivery in plain, discreet black padded packaging, with no product names on the outside. See shipping & delivery.
Frequently asked questions
What is Cagrilintide?
Cagrilintide is a long-acting analogue of amylin, a hormone released alongside insulin.
Is Cagrilintide a licensed medicine in the UK?
Cagrilintide is not a licensed medicine in the UK. Onyx Peptides supplies it only as a research material for in-vitro laboratory use.
How is Cagrilintide supplied?
Supplied as a lyophilised (freeze-dried) powder in a sealed glass vial. Store the sealed vial frozen (below −18 °C) and away from light. Each batch is HPLC-tested to at least 99% purity.
How is my order packaged?
In plain, discreet black padded packaging with no product names on the outside, sent by tracked UK delivery.
